Erratum: Comparative uterine effects on ovariectomized rats after repeated treatment with different vaginal estrogen formulations (Maturitas (2012) 72 (353-358) DOI: 10.1016/j.maturitas.2012.05.007);Comparative uterine effects on ovariectomized rats after repeated treatment with different vaginal estrogen formulations

Maturitas

Volumn 72, Issue 4, 2012, Pages 353-358

  López Belmonte, Juan ^a   Nieto, Concepción ^b   Estevez, José ^c   Delgado, Juan L ^d   Moscoso Del Prado, Jaime ^b  

^a Farma cros Iberica   (Spain)

^b Italfarmaco SA   (Spain)

^c HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

Author keywords

Estriol; Promestriene; Uterotrophic effect; Vaginal atrophy

Indexed keywords

COLPOTROFIN; ESTRIOL; OVESTINON; PLACEBO; PROMESTRIENE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG FORMULATION; ENDOMETRIUM; ESTROGEN ACTIVITY; FEMALE; GEL; HISTOPATHOLOGY; MYOMETRIUM; NONHUMAN; OVARIECTOMY; RAT; THICKNESS; TREATMENT DURATION; UTERUS RELAXATION; UTERUS WEIGHT; VAGINA ATROPHY;

ANIMALIA; RATTUS;

EID: 84863778725     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2012.12.012     Document Type: Erratum

References (31)

1. The North American Menopause Society. Estrogen and progestogen use in periand postmenopausal women: March 2007 position statement of The North American Menopause Society. Menopause 2007;14:168-82.
2. Moore DH, Chasseaud LF, Darragh A, Taylor T, Cresswell DG. The percutaneous absorption and excretion of promestriene (3-propoxy- 17βmethoxy-1,3,5(10)-estratriene) in rats and humans. Steroids 1983;41(1):15-22. (Pubitemid 14209065)
3. van Haaften M, Donker GH, Sie-Go DM, Haspels AA, Thijssen JH. Biochemical and histological effects of vaginal estriol and estradiol applications on the endometrium, myometrium and vagina of postmenopausal women. Gynecological Endocrinology 1997;11:175-85. (Pubitemid 27260797)
4. Wurch TA, Bursaux CD, Cohen A. Intérêt du promestriène dans le traitement de la vaginite atrophique post-ménopausique. Gynécologie 1981;32:551-6.
5. Wolff J-P, Cachelou R, Guériteé N. Absence of systemic hormonal effects in an oestradiol diether topically active on the vaginal mucosa. Maturitas 1982;4:239-46. (Pubitemid 13189092)
6. Borrelli AL, Casolaro AM, Esposito G, Berlingieri D. Attività biológica del promestriene sul tratto genitale della ratta castrata. Minerva Ginecologica 1990;42:467-72.
7. Bonneton A, Dechaud H, Fleury MC, Colau JC, Pugeat M. Absence d'influence du promestriène administré par voie vaginale sur le taux circulant des hormones et des proteínes hépatiques estrogéno dépendantes de la femme ménopauseé. Gynécologie 1992;43:45-8.
8. Thomas JT, Mignot A, Roger M, Guillaume M. Compared absorption of promestriene by vaginal and oral routes in postmenopausal women. In: Presented at the 9th International Congress of Endocrinology. 1992.
9. Thevenot R, Paris J, Bonnet T, Hazard MC, Krebs B, Milano G. Etude d'un dietherǐd'estrogène (promestriène DCI) sur la séborrhée expérimentale. Therapies 1976;31:771-84. (Pubitemid 8036561)
10. Tresca JP, Ponsard G, Pigne D, Jayle MF. Experimental data on estradiol 3,17- diethers (author's transl). Annales d Endocrinologie 1977;38:355-6. (Pubitemid 9014689)
11. Phillips A, Hahn DW, McGuire JL. Comparative effect of estriol and equine conjugated estrogens on the uterus and the vagina. Maturitas 1984;5: 147-52. (Pubitemid 14161528)
12. Gerbaldo D, Ferraiolo A, Croce S, Truini M, Capitanio GL. Endometrial morphology after 12 months of vaginal oestriol therapy in post-menopausal women. Maturitas 1991;13:269-74.
13. Vooijs GP, Geurts TB. Review of the endometrial safety during intravaginal treatment with estriol. European Journal of Obstetrics, Gynecology, and Reproductive Biology 1995;62(1):101-6.
14. Yoshimura T, Okamura H. Short term oral estriol treatment restores normal premenopausal vaginal flora to elderly women. Maturitas 2001;39:253-7. (Pubitemid 32900555)
15. Bryś M, Szyłło K, Romanowicz-Makowska H, Dobrowolski Z, Masłowska I, Krajewska W. Expression of estrogen and progesterone receptor genes in endometrium, myometrium and vagina of postmenopausal women treated with estriol. Sao Paulo Medical Journal 2009;127:128-33.
16. Mattsson LA, Cullberg G. Vaginal absorption of two estriol preparations. A comparative study in postmenopausal women. Acta Obstetricia et Gynecologica Scandinavica 1983;62:393-6. (Pubitemid 14213523)
17. Bottiglione F, Volpe A, Esposito G, Aloysio DD. Transvaginal estriol administration in postmenopausal women: a double blind comparative study of two different doses. Maturitas 1995;22:227-32.
18. Pfeiler G, Glatz C, Königsberg R, Geisendorfer T, Fink-Retter A, Kubista E, et al. Vaginal estriol to overcome side-effects of aromatase inhibitors in breast cancer patients. Climacteric 2011;14:339-44.
19. Delgado JL, Estévez J, Usandizaga R, de la Calle M, Castellanos E, Nieto C. Comparative pharmacokinetics and preliminary efficacy of two topical vaginal formulations of Estriol (0.005% Estriol vaginal gel, and 0.002% Estriol vaginal gel) vs. the marketed reference product (Ovestinon®, Estriol vaginal cream 0.1%) in post-menopausal healthy volunteers. Climateric 2011;14:66.
20. Cano A, Estevez J, Usandizaga R, et al. The therapeutic effect of a new ultra-low concentration estriol gel formulation (0.005% Estriol vaginal gel) on symptoms and signs of postmenopausal vaginal atrophy. Results from a pivotal phase III study. Menopause; 2012:9.
21. Clark JH, Guthrie SC. Stimulation of vaginal growth and cornification in the absence of estrogen or nuclear binding of the estrogen receptor. Journal of Steroid Biochemistry 1983;19:1239-40.
22. Fainstat T. Hormonal basis for collagen bundle generation in uterine stroma: extracellular studies of uterus. Endocrinology 1962;71:878-87.
23. Perez MC, Furth EE, Matzumura PD, Lyttle CR. Role of eosinophils in uterine responses to estrogen. Biology of Reproduction 1996;54:249-54. (Pubitemid 126506821)
24. Katayama ML, Federico MH, Brentani RR, Brentani MM. Eosinophil accumulation in rat uterus following estradiol administration is modulated by laminin and its integrin receptors. Cell Adhesion and Communication 1998;5:409-24.
25. O'Brien JE, Peterson TJ, Tong MH, et al. Estrogen-induced proliferation of uterine epithelial cells is independent of estrogen receptor alpha binding to classical estrogen response elements. Journal of Biological Chemistry 2006;281:26683-92. (Pubitemid 44401877)
26. Pastore GN, Dicola LP, Dollahon NR, Gardner RM. Effect of estriol on the structure and organization of collagen in the lamina propria of the immature rat uterus. Biology of Reproduction 1992;47:83-91.
27. Astwood EB. Changes in the weight and water content of the uterus of the normal adult rat. American Journal of Physiology 1939;126:172-260.
28. Kirkland JL, Gardner RM, Ireland JS, Stancel GM. The effect of hypophysectomy on the uterine response to estradiol. Endocrinology 1977;101:403-10. (Pubitemid 8162308)
29. Harris JN, Gorski J. Estrogen stimulation of DNA-dependent DNA polymerase activity in immature rat uterus. Molecular and Cellular Endocrinology 1978;10:293-305.
30. Galand P, Mairesse N, Roorijck J, Flandroy L. Differential blockade of estrogen-induced uterine responses by the antiestrogen nafoxidine. Journal of Steroid Biochemistry 1983;19:1259-63. (Pubitemid 13018568)
31. Tresca JP, Ponsard G, Jayle MF. Cinétiques de péné tration transcutanée et de fixation du 3-propyl éter, 17-méthyl éter oestradiol et de l'oestradiol au niveau de différents tissus chez la ratte. Canadian Journal of Biochemistry 1977;55:1092-102.